Everand Logo

Welcome to Everand!

  • STAT

    STAT+: Pharmalittle: We’re watching a ban of compounded versions of GLP-1s, a Biogen acquisition, and more

    Australia plans to ban compounded versions of blockbuster drugs Ozempic and Mounjaro.
    by Jonathan Wosen May 22, 2024 1 minute
    Source: Alex Hogan/STAT

    Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
    The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
    Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Abortion Pill Access, Employer Coverage Of GLP-1 Drugs And More
    Updates from the Pharmalittle newsletter campus: —FDA advised drugmakers to update Covid vaccines to target the KP.2 strain —Leadership from Done startup were arrested and charged with fraud —U.S. authorities…

    Related Books & Audiobooks